 |
 |
Mesothelioma: A Killer
Lurks in the Lungs |
 |
 |
Nighttime dosage cuts high blood pressure in blacks
Last Updated: 2004-09-30 15:34:31 -0400 (Reuters Health)
NEW YORK (Reuters Health) - A dose of long-acting diltiazem at bedtime is more effective than a morning dose of amlodipine in reducing high blood pressure in black patients, new study findings suggest. The drug works best at reducing blood pressure in the morning -- the time of day when heart attacks and strokes are most likely to occur.
The study was sponsored by Biovail Pharmaceuticals, which markets long-acting diltiazem under the name Cardizem, L.A.
The study, which is reported in the American Journal of Hypertension, involved 262 African Americans with high blood pressure who were randomly selected to receive Cardizem at nighttime or amlodipine in the morning for 6 weeks. Blood pressure and heart rate were measured continuously throughout the day.
Cardizem was more effective than amlodipine at reducing heart rate in the morning as well over 24 hours, lead author Dr. Jackson T. Wright, from Case Western Reserve University in Cleveland, and colleagues note.
Both drugs provided comparable reductions in 24-hour diastolic blood pressure (the lower number on a blood pressure reading), but Cardizem was better at reducing morning diastolic blood pressure.
In contrast, amlodipine provided greater reductions in 24-hour systolic blood pressure (the higher number on a blood pressure reading) than Cardizem.
Both agents were well tolerated and no unexpected or severe side effects were observed with either, the investigators state.
The reductions in blood pressure and heart rate achieved with Cardizem, especially during the early morning hours, "may provide advantages to patients at risk" for heart attacks and stroke, the authors conclude.
SOURCE: American Journal of Hypertension, September 2004.
Copyright © 2004 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
Continue with:
|